| payload |
{"created_at":"2026-04-08T12:49:17.656 {"created_at":"2026-04-08T12:49:17.656805+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/arcutis-stock-65-director-sells-10000-shares-under-10b5-1-plan-heres-what-investors-should","value":{"fp":"bcb37d5a8e25ba00","kind":"unusual_volume","published_at":"2026-04-08T11:50:19+00:00","source":"Nasdaq Markets","summary":"Key PointsA director of Arcutis Biotherapeutics reported selling 10,000 shares for a total transaction value of $239,000 on April 1, 2026.","tickers":[],"title":"Arcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know","url":"https://www.nasdaq.com/articles/arcutis-stock-65-director-sells-10000-shares-under-10b5-1-plan-heres-what-investors-should"}}... |